- Tỷ lệ đồng nhiễm HBV và HCV ở cả 2 nhóm đối tượng đều thấp; tuy rằng tỷ lệ này ở BNCTNT có phần cao hơn ở BNTMNL Không có sự khác
33. Nguyễn Chí Tuyển & Nguyễn Anh Trí (2004), "Kết quả sơ bộ tình hình thu gom máu và xét nghiệm sàng lọc các bệnh nhiễm trung qua đường
thu gom máu và xét nghiệm sàng lọc các bệnh nhiễm trung qua đường truyền máu tại các cơ sở truyền máu trong toàn quốc và tại Viện Huyết học-Truyền máu trung ương từ 1994 đến tháng 6/2004", Tạp chí Y học
thực hành, Bộ Y tế, 497, tr. 170-175.
34. Đinh Mai Vân, Giáp Thị Bích Thủy & Cộng sự (2009), "Nhiễm HIV và hành vi nguy cơ trong nhóm tiêm chích ma túy ở Thành phố Bắc và hành vi nguy cơ trong nhóm tiêm chích ma túy ở Thành phố Bắc Ninh", Tạp chí Y học Dự phòng, Bộ Y tế, Tập XIX, số 1(100), tr. 62-65.
35. Nguyễn Thị Tuyết Vân & Cộng sự (2008), "Tình hình nhiễm Vi rút viêm gan C trên người nghiện chích ma túy tại trại giam Đăk Trung, viêm gan C trên người nghiện chích ma túy tại trại giam Đăk Trung,
Gia Trung và trung tâm Giáo dục xã hội của Tây Nguyên", Tạp chí Y
học TP. Hồ Chí Minh, Tập 12(1), tr. 1-7.
36. Vũ Thị Tường Vân (2011), "Nghiên cứu nhiễm vi rút viêm gan C (HCV) ở người nghiện chích ma túy đến khám tại Bệnh viện Bạch Mai", Tạp ở người nghiện chích ma túy đến khám tại Bệnh viện Bạch Mai", Tạp
chí Y học thực hành, Bộ Y tế, 768(6), tr. 145-148.
37. Abbas, Z. & al. (2011), "Management of hepatitis B in developing countries", World Hepatol. Journal, 3(12), pp. 292-299. countries", World Hepatol. Journal, 3(12), pp. 292-299.
38. Aceijas, C. & al. (2004), "Global overview of injecting drug use and HIV infection among injecting drug users", AIDS journal, 18, pp. 2295- infection among injecting drug users", AIDS journal, 18, pp. 2295- 2303.
39. Aceijas, C. & Rhodes, T. (2007), "Global estimates of prevalence of HCV infection among injecting drug users", Int. Drug Policy Jouranl, HCV infection among injecting drug users", Int. Drug Policy Jouranl,
18(5), pp. 352-8.
40. Alavian, S. M. & Fallahian, F. (2009), "Epidemiology of hepatitis C in Iran and the world", Shiraz E-Medical J., 10(4), pp. 1-13. Iran and the world", Shiraz E-Medical J., 10(4), pp. 1-13.
41. Alter, H. J. & Liang, T. J. (2012), "Hepatitis C: The End of the Beginning and Possibly the Beginning of the End", Annals of Internal Beginning and Possibly the Beginning of the End", Annals of Internal Med. Journal, Vol. 156(4), pp. 317-319.
42. Alter, M. J. (2007), "Epidemiology of hepatitis c virus infection", World Gastroenterol. J., 13(17), pp. 2436-2441. Gastroenterol. J., 13(17), pp. 2436-2441.
43. Alter, M. J. (2006), "Epidemiology of viral hepatitis and HIV-coinfection", Hepatology journal, 44, pp. S6-S9. coinfection", Hepatology journal, 44, pp. S6-S9.
44. Aman, W. & al. (2012), "Current status and future directions in the management of chronic hepatitis C", Virology Journal, 9, pp. 57-78. management of chronic hepatitis C", Virology Journal, 9, pp. 57-78.
45. Anastassopoulou, C. G. & Kostrikis, L. G. (2006), "Global Genetic variation of HIV-1 infection", Current HIV Research Journal, Vol. variation of HIV-1 infection", Current HIV Research Journal, Vol. 4(3), pp. 365-373.
46. Anbazhagan, G. K. & al. (2010), "Seroprevalence of HCV and its co-infection with HBV and HIV among liver disease patients ò South infection with HBV and HIV among liver disease patients ò South Tamil Nadu", W. Hepatology Journal, 2(1), pp. 42-48.
47. Archer, J. & Robertson, A. (2007), "Understanding the diversification of HIV-1 groups M and O", AIDS Journal, 21, pp. 1693-1700. HIV-1 groups M and O", AIDS Journal, 21, pp. 1693-1700.
48. Aroldi, A. (2005), "Natural history of hepatitis B and C in renal allograft recipients", Transplantation Journal, 79, (9), pp. 1132. recipients", Transplantation Journal, 79, (9), pp. 1132.
49. Ashfaq, U. A. & al. (2011), "An overview of HCV molecular biology, replication and immune responses", Virology Journal, 8(161), pp. 1-10. replication and immune responses", Virology Journal, 8(161), pp. 1-10.
50. Attaullah, S., Khan, S., Ayaz, S. & al. (2011), "Prevalence of HBV and HBV vaccination coverage in health care workers of tertiary and HBV vaccination coverage in health care workers of tertiary hospitals of Peshawar, Pakistan", Virology Journal, 8, pp. 275-286.
51. Attaullah, S., Khan, S. & Khan, J. (2012), "Trend of transfusion transmitted infections frequency in blood donors: provide a road map transmitted infections frequency in blood donors: provide a road map for its prevention and control", Translational Medicine Journal, 10, pp. 20-24.
52. Ayesh, B. M., Zourob, S. & Abu-Jadallah, S. (2009), "Most common genotypes and risk factors for HCV in Gaza strip: a cross sectional genotypes and risk factors for HCV in Gaza strip: a cross sectional study", Virology Journal, 6, pp. 105.
53. Baral, S. & al. (2007), "Vaccine immunogenicity in injecting drug users: a systematic review", Lancet Infect. Dis. J., 7, pp. 667-74. a systematic review", Lancet Infect. Dis. J., 7, pp. 667-74.
54. Bartosch, B. (2010), "Hepatitis B and C Viruses and Hepatocellular Carcinoma", Viiruses Journal, 2, pp. 1504-1509. Carcinoma", Viiruses Journal, 2, pp. 1504-1509.
55. Belasio, E. F., Raimondo, M. & Butto, S. (2010), "HIV virology and pathogenesis mechanisms of infection: a brief overview", Ann Ist. pathogenesis mechanisms of infection: a brief overview", Ann Ist. Super Sanita J., Vol. 46(1), pp. 5-14.
56. Benhamou, Y. (2004), "Antiretroviral therapy and HIV/hepatitis B virus coinfection", Clin. Infect. Dis. J., 38 (2), pp. S98-103. coinfection", Clin. Infect. Dis. J., 38 (2), pp. S98-103.
57. Bihl, F., Castelli, D. & al. (2007), "Transfusion-Transmitted infections",
Translational Medicine Journal, 5(25), pp. 1-11.
58. Bosevska, G., Kuzmanovska, G. & al. (2009), "Screening for hepatitis B, C and HIV infection among patients on haemodialysis." B, C and HIV infection among patients on haemodialysis."
Contribution, Sec. Biol. Med. Sci. J., Vol. XXX(2), pp. 159-174.
59. Brook, G., Main, J., Nelson, M. & al. (2010), "British HIV Association guidelines for the management of coinfection with HIV-1 Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010", HIV Medicine Journal, 11, pp. 1-30.
60. Brook, G., Soriano, V. & Bergin, C. (2010), "European guideline for the management of hepatitis B and C infections, 2010", Intern STD & the management of hepatitis B and C infections, 2010", Intern STD & AIDS Journal, 21, pp. 669-678.
61. Brook, M. G. (2006), "Prevention of viral hepatitis in HIV co-infection",
Hepatology Journal, 44, pp. S104-S107.
62. Buffington, J. & Jones, T. S. (2007), "Integrating Viral Hepatitis Prevention into Public Health Programs Serving People at High risk for Prevention into Public Health Programs Serving People at High risk for Infection: Good Public Health ", Public Health Reports Journal, Vol. 122(Supp. 2), pp. 1-5.
63. Burban, S. D. & Yazdanpanah, Y. (2012), "It is Time to Change the Paradigm for Hepatitis C Virus Testing", Clinic. Infect. Dis. Journal, Paradigm for Hepatitis C Virus Testing", Clinic. Infect. Dis. Journal,
54(9), pp. 1272-4.
64. Buskin, S. E. & al. (2011), "Hepatitis B and C infection and liver disease trends among human immunodeficiency virus-infected individuals", trends among human immunodeficiency virus-infected individuals",
World Gastroenterol Journal, Vol. 17(14), pp. 1807-1816.
65. Butler, I. F., Pandrea, I. & Marx, P. A. (2007), "HIV Genetic Diversity: Biological and Public Health Consequences", Current HIV Diversity: Biological and Public Health Consequences", Current HIV Research Journal, Vol. 5, pp. 23-45.
66. Cabibbo, G. & Craxi, A. (2010), "Epidemiology, risk factors and surveillance of hepatocellular carcinoma", Eur. Rev. Med. Pharmacol. surveillance of hepatocellular carcinoma", Eur. Rev. Med. Pharmacol. Sci., 14, pp. 352-355.
67. Candotti, D. & Allain, J. P. (2009), "Transfusion-transmitted hepatitis B virus infection", Hepatology Journal, 51, pp. 798-809. virus infection", Hepatology Journal, 51, pp. 798-809.
68. Chak, E., Talal, A. H. & Serman, K. E. (2011), "Hepatitis C virus infection in USA: an estimate of true prevalence", Liver International infection in USA: an estimate of true prevalence", Liver International Journal, pp. 1090-1101.
69. Chao, D. T., Abe, K. & Nguyen, M. H. (2011), "Systematic review: epidemiology of hepatitis C genotype 6 and its management", Aliment. epidemiology of hepatitis C genotype 6 and its management", Aliment. Phamacol. Ther. Journal, 34, pp. 286-296.
70. Chen, Y. J. & al. (2010), "Molercular Epidemiology of HIV-1 subtype B, CRF01_AE and CRF07_BC Infection among injection drug users in CRF01_AE and CRF07_BC Infection among injection drug users in Taiwan", Acquir. Immune Defic. Sydr. Journal, 53(4), pp. 425-439.
71. Chiavetta, J. A., Escobar, M., Newman, A. & al. (2003), "Incidence and estimated rates of residual risk for HIV, hepatitis C hepatitis B and and estimated rates of residual risk for HIV, hepatitis C hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990- 2000", Canada Medical A. J., 169(8), pp. 12-15.
72. Chinen, J. & Shearer, W. T. (2002), "Molecular virology and immunology of HIV infection ", Allergy Clin. Immunol. Journal, 110, immunology of HIV infection ", Allergy Clin. Immunol. Journal, 110, pp. 189-98.
73. Chu, C. J. & Lee, S. D. (2008), "Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and coinfection: Epidemiology, clinical features, viral interactions and treatment", Gastroenterology and Hepatology Journal, 23(4), pp. 512- 520.
74. Cohen, M. S. & Gay, C. L. (2010), "Treatment to prevent transmission of HIV-1", Clin. Infect. Dis. Journal, 50(Suppl 3), pp. S85-95. HIV-1", Clin. Infect. Dis. Journal, 50(Suppl 3), pp. S85-95.
75. Demetriou, V. L. & al. (2010), "Hepatitis C Infection among Intravenous drug users attending therapy programs in Cyprus", Med. Virol. Journal, drug users attending therapy programs in Cyprus", Med. Virol. Journal,
82, pp. 263-270.
76. Drosten, C. & al. (2006), "Ultrasensitive Monitoring of HIV-1 Viral Load by a Low Cost Real-Time Reverse Transcription-PCR Assay with Load by a Low Cost Real-Time Reverse Transcription-PCR Assay with Internal Control for the 5' Long Terminal Repeat Domain", Clinical Chemistry Journal, 52(7), pp. 1258-1266.
77. Easterbrook, E. & al. (2010), "Impact of HIV-1 viral subtype on disease progression and response to antirestroviral therapy", The International progression and response to antirestroviral therapy", The International AIDS Society Journal, 13, pp. 4.
78. Edey, M. & al. (2010), "Review article: Hepatitis B and dialysis",
Nephrology Journal, Vol.15, pp. 137-145.
79. Eida, M. (2010), "Chronic hepatitis C genotype 4 treatment in chronic haemodialysis patients: A restrospective study", Arab gastroenterology haemodialysis patients: A restrospective study", Arab gastroenterology Journal, 11, pp. 83-87.
80. Eleftheriadis, T., Liakopoulos, V. & Leivaditis, K. (2011), "Infection in hemodialysis: a concise review. Part II: Blood transmitted viral in hemodialysis: a concise review. Part II: Blood transmitted viral infections", Hippokratia Journal, 15(2), pp. 120-126.
81. Elserag, H. B. (2011), "Hepatocellular carcinoma", New England Med. J.,
365, pp. 1118-27.
82. Espirito, M. P., Carneiro, M. A. S., Reis, N. R. S. & al. (2007),
"Genotyping hepatitis C virus from hemodialysis patients in Central Brazil by line probe assay and sequence analysis", Braz. Med. Biol. Res. Journal, 40, pp. 545-550.
83. Fabrizi, F. & Martin, P. (2008), "Transmission of hepatitis C virus in the hemodialysis setting", Hot Topics in Viral Hepatitis Journal, 11, pp. hemodialysis setting", Hot Topics in Viral Hepatitis Journal, 11, pp. 13-18.
84. Fallahian, F., Najafi, A. & Alavian, S. M. (2010), "Intravenous Drug Use: the Predominant Risk Factors for Hepatitis C Virus Infection", Use: the Predominant Risk Factors for Hepatitis C Virus Infection",
Shoraz E- Medical J., 11, (4), pp. 4-14.
85. Filipowicz, M. S. (2010), "Interferon therapy of hepatitis C: Molecular insights into success and failure", Swiss Med. Weekly Journal, 140(1- insights into success and failure", Swiss Med. Weekly Journal, 140(1- 2), pp. 3-11.
86. Ford, N. & al. (2012), "Expanding Access to Treatment for Hepatitis C in Resource-Limited Settings: Lessons From HIV/AIDS", Clinic. Infect. Resource-Limited Settings: Lessons From HIV/AIDS", Clinic. Infect. Dis. Journal, DOI: 10.1093/cid/cis227, pp. 1-8.
87. Franchini, M. & al. (2002), "Update on chronic hepatitis C in hemophiliacs", Haematological Journal, 87, pp. 542-549. hemophiliacs", Haematological Journal, 87, pp. 542-549.
88. Franchini, M. & al. (2008), "Treatment of chronic hepatitis C in haemophilic patients with interferon and ribavirin: a meta-analysis", haemophilic patients with interferon and ribavirin: a meta-analysis",
Antimicrobial Chemotherapy Journal, 61, pp. 1191-1200.
89. Franco, E. & al. (2012), "Hepatitis B: Epidemiology and prevention in developing countries", World J. Hepatol., Vol. 4(3), pp. 74-80. developing countries", World J. Hepatol., Vol. 4(3), pp. 74-80.
90. Galetto, R. & Negroni, M. (2005), "Mechanistic Features of recombination in HIV", AIDS Reviews Journal, Vol.7, pp. 92-102. recombination in HIV", AIDS Reviews Journal, Vol.7, pp. 92-102.
91. Garcia-Calleja, J. M., Gouws, E. & Ghys, P. D. (2006), "National population based HIV prevalence surveys in sub-Saharan Africa: result population based HIV prevalence surveys in sub-Saharan Africa: result and omplications for HIV and AIDS estimates", Sex. Transm. Infect. Journal, 82, pp. iii64-iii70.
92. Garson, J. A. & al. (2005), "Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine virus DNA using automated sample preparation and murine cytomegalovirus internal control", Clinical Virology Journal, 126, pp. 207-213.
93. Gordon, C. E., Uhlig, K. & Lau, J. (2009), "Interferon for Hepatitis C Virus in Hemodialysis-an Individual Patients Meta-analysis of Factors Virus in Hemodialysis-an Individual Patients Meta-analysis of Factors
Associated with Sustained Virological Response." Clin. Am. Soc. Nephrol. Journal, 4, pp. 1449-1458.
94. Gutierrez, M., Tajada, P., Alvarez, A. & al. (2004), "Prevalence of HIV-1 non-B subtypes, Syphilis, HTLV and hepatitis B and C viruses HIV-1 non-B subtypes, Syphilis, HTLV and hepatitis B and C viruses among immigrant sex workers in Madrid, Spain", Med. Virol. Journal,
74(4), pp. 521-7.
95. Hagan, H. (2011), "Agent, Host, and En vironment: Hepatitis C Virus in People who Inject Drugs", IInfect. Dis. Journal, 204, pp. 1819-21. People who Inject Drugs", IInfect. Dis. Journal, 204, pp. 1819-21.
96. Hagan, H., Pouget, E. R. & Jarlais J.C (2011), "A Systematic Review and Meta-Analysis of Intervention to Prevent Hepatitis C virus and Meta-Analysis of Intervention to Prevent Hepatitis C virus Infection in People Who Inject Drugs", Infectious Diseases Journal,
204, pp. 74-83.
97. Hamissi, J. & Hamissi, H. (2011), "Occurence of hepatitis B and C infection among hemodialyzed patients with chronic renal failure in infection among hemodialyzed patients with chronic renal failure in Qazvin, Iran: A preliminary study", Int. J. of Coll. Res. on Inter. Med. & Pub. Health, Vol. 3(1), pp. 88-96.
98. Han, L. & Wang, S. (2010), "Hepatitis C viral infection in a Chinese hemodialysis unit", Chin. Med. Journal, 123(24), pp. 3574-3577. hemodialysis unit", Chin. Med. Journal, 123(24), pp. 3574-3577.
99. Harnois, D. M. (2012), "Hepatitis C virus Infection and the rising Incidence of Hepatocellular Carcinoma", MayoClin. Proc. Journal, Incidence of Hepatocellular Carcinoma", MayoClin. Proc. Journal,
87(1), pp. 7-8.
100. Hellard, M., Davis, R. S. & Gold, J. (2009), "Hepatitis C treatment for Injection drug users: A review of the available evidence", Clinic. Infect. Injection drug users: A review of the available evidence", Clinic. Infect. Dis. Journal, 49, pp. 561-73.
101. Hemelaar, J., Gouws, E. & Ghys, P. D. (2006), "Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004", distribution of HIV-1 genetic subtypes and recombinants in 2004",
102. Higgs, P. & al. (2011), "Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence", Hepat. Mon. Journal, people who inject drugs: Myths and evidence", Hepat. Mon. Journal,
11(7), pp. 513-518.
103. Hnatyszyn, H. J. (2005), "Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes", Antivir. Ther. clinical significance of determining HCV genotypes", Antivir. Ther. Journal, 10(1), pp. 1-11.
104. Holguín, A. & al. (2000), "Recombinant Human Immunodeficiency Viruses Type 1 Circulating in Spain", AIDS Res. and Human Retrovir. Viruses Type 1 Circulating in Spain", AIDS Res. and Human Retrovir. Journal, 16(5), pp. 505-511.
105. Hosseini-Moghaddam, S. M. & al. (2006), "Distribution of hepatitis c virus genotypes among hemodialysis patients in Teheran multicenter virus genotypes among hemodialysis patients in Teheran multicenter study", Medical Virology Journal, Vol. 78(5), pp. 569-573.
106. Hou, J. L., Liu, Z. & Gu, F. (2005), "Epidemiology and Prevention of Hepatitis B Virus Infection", Intn'. Med. Sci. Journal, 2(1), pp. 50-57. Hepatitis B Virus Infection", Intn'. Med. Sci. Journal, 2(1), pp. 50-57.
107. Hwang, E. W. & Cheung, R. (2011), "Global Epidemiology of Hepatitis B Virus (HBV) Infection", Nor. A. of Med. and Sciences Hepatitis B Virus (HBV) Infection", Nor. A. of Med. and Sciences Journal (NAJMS) 4(1), pp. 7-13.
108. Jacobson, I. M., Davis, G. L. & Serag, H. E. (2010), "Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection", Clin. Gastroenterol. and Hepat. Journal, 8, pp. 924- 933.
109. Jarlais, C. D. & Semaan, S. (2008), "HIV prevention for Injecting Drug Users: The First 25 Years and Counting", Psychosomatic Medicine Users: The First 25 Years and Counting", Psychosomatic Medicine Journal, 70, pp. 606-611.
110. Jasuja, S. & Gupta, A. K. (2009), "Prevalence and associations of hepatitis C viremia in hemodialysis patients at a tertiary care hospital", hepatitis C viremia in hemodialysis patients at a tertiary care hospital",
111. Johnson, D. W., Dent, H. & Yao, Q. (2009), "Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data", Nephrol Dial. Transplant Journal, 24, pp. 1598-1603.
112. Joukar, F. & al. (2011), "Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, associated risk factors in hemodialysis patients in Guilan province, north of Iran", Hepat. Mon. Journal, 11(3), pp. 178-181.
113. Kalichman, S. & Eaton, L. (2009), "Strategies for preventing HIV transmission." JAMA, 302, pp. 1531-1532. transmission." JAMA, 302, pp. 1531-1532.
114. Kallings, L. O. (2008), "The first postmodern pandemic: 25 years of HIV/AIDS", Internal Medicine Journal, 263, pp. 218-243. HIV/AIDS", Internal Medicine Journal, 263, pp. 218-243.
115. Kao, J. H. (2011), "Molecular Epidemiology of Hepatitis B Virus",
Korean Intern. Med. Journal, Vol. 26(3), pp. 255-261.